HEB : Analysis & Opinions

  1. Hemispherx 3Q Loss $2.9M or 13 Cents a Share (HEB)

    November 16, 2016
    Hemispherx Biopharma posted a 3Q loss of 13 cents a share, compared to 18 cents last year.
Trading Center